HASEGAWA Ryuichi | Division of Medical Safety Science, National Institute of Health Sciences
スポンサーリンク
概要
関連著者
-
HASEGAWA Ryuichi
Division of Medical Safety Science, National Institute of Health Sciences
-
SAITO Yoshiro
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
SAWADA Jun-ichi
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
Umemura T
Division Of Pathology National Institute Of Health Sciences
-
Kawamoto Manabu
Division Of Genomic Medicine Department Of Advanced Biomedical Engineering And Science Tokyo Women&a
-
Yoshida S
Chiba University
-
UMEMURA Takashi
Division of Pathology, National Institute of Health Sciences
-
Kitajima Satoshi
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Satoh Kanako
東京都健康安全研究センター 環境保健部
-
Kaniwa N
Department Of Genome Biology Kinki University School Of Medicine
-
Sai-kato Kimie
Division Of Toxicology
-
Kitakaze Masafumi
Division Of Cardiology National Cardiovascular Center
-
Nishikawa Akiyoshi
Division of Pathology, National Institute of Health Sciences
-
Kawamoto Manabu
Institute Of Rheumatology Tokyo Women's Medical University
-
Kanzaki Hideaki
国立循環器病センター 心臓血管内科
-
Saito Yoshiro
国立医薬品食品衛生研究所
-
Koseki Masahiro
大阪大学 医学系研究科循環器内科学
-
Sawada Junichi
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Kamatani Naoyuki
国立医薬品食品衛生研究所 薬物応答予測プロジェクト
-
Maekawa Keiko
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Sai Kimie
Divislon Of Toxicology National Institute Of Health Sciences
-
Sai Kimie
Division Of Biosignaling National Institute Of Health Sciences
-
Kitakaze Masafumi
国立循環器病センター 心臓血管
-
Kurose Kouichi
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
SAITO Yasushi
Chiba University
-
Kamakura Shiro
Division of Cardiology, National Cardiovascular Center
-
Hirose Akihiko
Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Science
-
SUZUKI Yoshihiko
Suzuki clinic
-
MAEKAWA Keiko
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
Komamura K
Department Of Cardiovascular Dynamics Research Institute National Cardiovascular Center
-
MINAMI Narihiro
National Center Hospital for Mental, Nervous, and Muscular Disorders National Center of Neurology an
-
Saito Y
Division Of Cardiovascular Medicine Kumamoto University Graduate School Of Medical Sciences
-
Yamashita Shizuya
大阪大学 医学系研究科循環器内科学
-
Saito Yoshihiko
Department Of Clinical Cell Biology Chiba University Graduate School Of Medicine
-
Sai Kimie
Div. Of Toxicology Biological Safety Research Center National Institute Of Hygienic Sciences
-
KUROSE Kouichi
Project team for Pharmacogenetics, National Institute of Health Sciences
-
FUKUSHIMA UESAKA
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
TOHKIN Masahiro
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
KOMAMURA Kazuo
Division of Cardiology, National Cardiovascular Center
-
UENO Kazuyuki
Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences
-
Kitakaze Masafumi
Nagoya University Graduate School Of Medicine
-
Takegawa K
Division Of Pathology National Institute Of Health Sciences:safety Evaluation Drug Development Labor
-
Takegawa Kiyoshi
三菱ウェルファーマ
-
Takada Koichi
Safety Evaluation Laboratory Yoshitomi Pharmaceutical Industries Co. Ltd.
-
Takegawa K
Toxicology Laboratories Pharmaceutical Research Division Mitsubishi Pharma Corporation
-
Takegawa Kiyoshi
Department Of Pathology National Institute Of Health Sciences
-
Hayashi Keiko
Division Of Internal Medicine And Thoracic Oncology National Cancer Center Hospital
-
Suzuki Sachiko
Division Of Toxicology Biological Safety Research Center National Institute Of Health Sciences
-
Hirose Masao
Division of Pathology, National Institute of Health Sciences
-
YOSHIDA Teruhiko
Genetics Division, National Cancer Center Research Institute
-
KAWAMOTO Manabu
Division of Genomic Medicine, Department of Advanced Biomedical Engineering and Science, Tokyo Women
-
KAMATANI Naoyuki
Division of Genomic Medicine, Department of Advanced Biomedical Engineering and Science, Tokyo Women
-
OZAWA Shogo
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
Mori H
Division Of Pathology National Institute Of Health Sciences
-
Kawamoto Manabu
国立医薬品食品衛生研究所
-
Kamide Kei
国立循環器病センター 高血圧腎臓内科
-
Miyashita K
Department Of Cardiovascular Surgery National Cardiovascular Center
-
KANKI Keita
Division of Pathology, National Institute of Health Sciences
-
IMAZAWA Takayoshi
Division of Pathology, National Institute of Health Sciences
-
KITAMURA Yasuki
Division of Pathology, National Institute of Health Sciences
-
Hirose Akihiko
National Inst. Of Health Sciences
-
Nishimura T
Division Of Environmental Chemistry
-
KIMURA Kenjiro
St. Marianna University School of Medicine
-
Kosuge Kotoko
日本大学 医学部内科学系腎臓高血圧内分泌内科
-
Kosuge Kotoko
Division Of Nephrology Hypertension And Endocrinology Department Of Medicine Nihon University School
-
Saito Y
Department Of Cardiovascular Medicine Osaka University Graduate School Of Medicine
-
Hamaguchi Tetsuya
国立がんセンター中央病院 消化管内科グループ
-
Hamano Tetsutaro
国立がんセンター中央病院 腫瘍内科
-
Tamura T
Division Of Internal Medicine National Cancer Center Hospital
-
NISHIMURA Tetsuji
Division of Environmental Health, National Institute of Health Sciences
-
Kodama K
Cardiovascular Division Osaka Police Hospital
-
Kosuge Masami
Yokohama City University School Of Medicine
-
Suzuki Shugo
名古屋市立大学 医学研究科実験病態病理学分野
-
Yoshida Teruhiko
Genetics Division National Cancer Center Research Institute National Cancer Center
-
Yoshida Teruhiko
国立循環器病センター 疫学部
-
Saijo N
Division Of Internal Medicine National Cancer Center Hospital East
-
Saijo Nagahiro
国立医薬品食品衛生研究所
-
Saijo N
Medical Oncology National Cancer Center Hospital
-
Takegawa Kiyoshi
Division of Pathology, National Institute of Health Sciences
-
Ohtsu A
Gastrointestinal/oncology Division National Cancer Center Hospital
-
KANIWA Nahoko
Project team for Pharmacogenetics, National Institute of Health Sciences
-
SUGIYAMA Emiko
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
SUZUKI Kazuko
Nerima General Hospital
-
YANAGAWA Tatsuo
Nerima General Hospital
-
KAJIO Hiroshi
Division of Endocrine and Metabolic Diseases, the Hospital
-
KUZUYA Nobuaki
Division of Endocrine and Metabolic Diseases, the Hospital
-
YASUDA Kazuki
Department of Metabolic Disorder, Research Institute, International Medical Center of Japan
-
GOTO Yu-ichi
National Institute of Neuroscience, National Center of Neurology and Psychiatry
-
KIMURA Hideo
National Institute of Neuroscience, National Center of Neurology and Psychiatry
-
KATOH Masaaki
National Center Hospital for Mental, Nervous and Muscular Disorders, National Center of Neurology an
-
SUGAI Kenji
National Center Hospital for Mental, Nervous and Muscular Disorders, National Center of Neurology an
-
Yamamoto Noboru
国立医薬品食品衛生研究所
-
Yamamoto N
Thoracic Oncology Division National Cancer Center Hospital National Cancer Center
-
Saeki Mayumi
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Tamura Tomohide
国立がんセンター中央病院 腫瘍内科
-
Tamura T
National Cancer Center Hospital Tokyo
-
Tamura Tomohide
Medical Oncology Division National Cancer Center Hospital
-
Takegawa Kiyoshi
Safety Evaluation Drug Development Laboratories Pharmaceutical Research Division Yoshitomi Pharmaceu
-
Ohe Yuichiro
国立医薬品食品衛生研究所
-
Ohe Yuichiro
Department Of Medical Oncology National Cancer Center Hospital
-
Kurose K
Department Of Vascular Physiology Research Institute National Cardiovascular Center
-
Kawasaki Nana
Division Of Biological Chemistry And Biologicals National Institute Of Health Sciences
-
KITAKAZE Masafumi
Division of Cardiology, National Cardiovascular Center
-
TOMOIKE Hitonobu
Division of Preventive Cardiology, National Cardiovascular Center
-
LEE Sang
Department of Pulmonary and Critical Care Medicine, Gachon University, Gil Medical Center
-
MITSUMORI Kunitoshi
Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology
-
Kitamura K
Department Of Geriatric Medicine Ehime University Graduate School Of Medicine
-
Kikuchi Kenjiro
Second Department Of Internal Medicine Sapporo Medical College
-
Nonogi Hiroshi
国立循環器病センター研究所 疫学部
-
Naritomi Hiroaki
Division Of Cardiology National Cardiovascular Center
-
Nakagami Hironori
Division Of Gene Therapy Science Osaka University Graduate School Of Medicine
-
Nonogi H
Division Of Cardiology Department Of Internal Medicine National Cardiovascular Center
-
EGUCHI NAKAJIMA
Gastrointestinal Oncology Division, National Cancer Center Hospital
-
YAMADA Yasuhide
Gastrointestinal Oncology Division, National Cancer Center Hospital
-
KATO Ken
Gastrointestinal Oncology Division, National Cancer Center Hospital
-
HAMAGUCHI Tetsuya
Gastrointestinal Oncology Division, National Cancer Center Hospital
-
SHIMADA Yasuhiro
Gastrointestinal Oncology Division, National Cancer Center Hospital
-
KIM Su-Ryang
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
MINAMI Hironobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Noda Takashi
国立循環器病センター 心臓血管内科
-
Kamakura Shiro
国立循環器病センター
-
FURUKAWA Fumio
Division of Pathology, National Institute of Health Sciences
-
OKAZAKI Kazushi
Division of Pathology, National Institute of Health Sciences
-
Saito Y
National Inst. Health Sci. Tokyo Jpn
-
Eguchi Nakajima
Gastrointestinal Oncology Division National Cancer Center Hospital
-
Kim Su-ryang
国立医薬品食品衛生研究所
-
Kim Su-ryang
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Sawada Jun-ichi
国立医薬品食品衛生研究所
-
Sawada J
National Inst. Health Sci. Tokyo Jpn
-
Ozawa Shogo
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Ozawa Shogo
国立医薬品食品衛生研究所
-
Hamaguchi T
Gastrointestinal Oncology Division National Cancer Center Hospital
-
Hamaguchi T
Gastrointestinal Oncology Division National Cancer Center Hospital National Cancer Center
-
Hamaguchi Tetsuya
Data Storage Systems Division Hitachi Ltd.
-
Yamada Y
Gastrointestinal Oncology Division National Cancer Center Hospital
-
Yamada Yasuhide
国立がんセンター中央病院 消化管内科グループ
-
Yamada Yasuhide
国立がんセンター中央病院
-
Yamada Yasuhide
Medical Oncology Division National Cancer Center Hospital
-
Kasai Satoshi
国立循環器病センター 心臓血管内科
-
MARUYAMA Satoshi
Division of Pathology, National Institute of Health Sciences
-
Komamura Kazuo
Department Of Cardiovascular Dynamics Research Institute National Cardiovascular Center
-
Kario Kazuomi
自治医科大学 地域医療学
-
Hirose Masao
国立医薬品食品衛生研究所 病理
-
SAI Kimie
Project team for Pharmacogenetics, National Institute of Health Sciences
-
OHTSU Atsushi
Division of GI Oncology/Digestive Endoscopy, National Cancer Center Hospital East
-
Okazaki K
Toxicology Division Gotemba Laboratory Bozo Research Center Inc.
-
Okazaki Kazushi
国立医薬品食品衛生研究所 病理部
-
Okazaki Kazushi
Gotemba Laboratory Bozo Research Center Inc.
-
Okazaki Kazushi
Division Of Pathology National Institute Of Health Sciences
-
Shirao Kuniaki
Gastrointestinal Oncology Division National Cancer Center Hospital
-
Sai Kimie
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Minami Hironobu
Division Of Oncology/hematology National Cancer Center Hospital East
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
Minami Hironobu
名古屋第一赤十字病院
-
Minami Hironobu
National Cancer Center Hospital East
-
Ohtsu Atsushi
Division Of Gastrointestinal Oncology/digestive Endoscopy National Cancer Center Hospital East
-
Ohtsu Atsushi
国立医薬品食品衛生研究所 機能生化学部
-
Nakajima T
National Center For Child Health And Dev. Tokyo Jpn
-
Nakajima Toshiharu
国立医薬品食品衛生研究所
-
Kamakura Shiro
国立医薬品食品衛生研究所 機能生化学部
-
KATORI Noriko
Project team for Pharmacogenetics, National Institute of Health Sciences
-
YAMAMOTO Noboru
Thoracic Oncology Division, National Cancer Center Hospital, National Cancer Center
-
KUNITOH Hideo
Thoracic Oncology Division, National Cancer Center Hospital, National Cancer Center
-
OHE Yuichiro
Thoracic Oncology Division, National Cancer Center Hospital, National Cancer Center
-
NOKIHARA Hiroshi
Thoracic Oncology Division, National Cancer Center Hospital, National Cancer Center
-
TAMURA Tomohide
Thoracic Oncology Division, National Cancer Center Hospital, National Cancer Center
-
SAIJO Nagahiro
Deputy Director, National Cancer Center Hospital East
-
SHIRAO Kuniaki
Division of Internal Medicine, National Cancer Center Hospital
-
YAMAMOTO Noboru
Division of Internal Medicine, National Cancer Center Hospital
-
TAMURA Tomohide
Division of Internal Medicine, National Cancer Center Hospital
-
MATSUMURA Yasuhiro
Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Ho
-
SAEKI Mayumi
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
DOI Toshihiko
Division of GI Oncology/Digestive Endoscopy, National Cancer Center Hospital East
-
SAITOH Osamu
National Center Hospital for Mental, Nervous and Muscular Disorders, National Center of Neurology an
-
KAWAI Mitsuru
National Center Hospital for Mental, Nervous and Muscular Disorders, National Center of Neurology an
-
OHNUMA Teiichi
National Center Hospital for Mental, Nervous and Muscular Disorders, National Center of Neurology an
-
OHTSUKI Taisuke
National Center Hospital for Mental, Nervous and Muscular Disorders, National Center of Neurology an
-
SUZUKI Chieko
National Center Hospital for Mental, Nervous and Muscular Disorders, National Center of Neurology an
-
KOYANO Satoru
Project team for Pharmacogenetics, National Institute of Health Sciences
-
SAIJO Nagahiro
Division of Internal Medicine, National Cancer Center Hospital, National Cancer Center
-
NAKAJIMA Yukiko
Project Team for Pharmacogenetics, National Institute of Health Science
-
OHNO Yasuo
Division of Pharmacology, National Institute of Health Science
-
Katori Noriko
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Saeki Mayumi
国立医薬品食品衛生研究所 機能生化学部
-
Saeki Mayumi
Project Team For Pharmacogenetics National Intitute Of Health Sciences
-
Ueno K
Department Of Pharmaceutical Sciences Niigata University Of Pharmacy And Applied Life Sciences
-
Ueno Kazuyuki
国立医薬品食品衛生研究所 薬物応答予測プロジェクト
-
Ueno Kazuyuki
新潟薬科大学 薬剤学
-
Tomoike Hitonobu
Division Of Preventive Cardiology National Cardiovascular Center
-
Tomoike Hitonobu
国立循環器病センター 疫学部
-
Tamura Tomohide
国立がんセンター中央病院 相談支援センター
-
Tamura Tomohide
Medical Oncology National Cancer Center Hospital
-
Ohe Yuichiro
Thoracic Oncology Division National Cancer Center Hospital National Cancer Center
-
Ohe Yuichiro
Department Of Internal Medicine National Cancer Center Hospital
-
Kurose Kouichi
Project Team For Pharmacogenetics National Intitute Of Health Sciences
-
Hashimoto Katsuji
Division Of Cardiology National Cardiovascular Center
-
Kunitoh Hideo
国立医薬品食品衛生研究所
-
Koyano Satoru
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Koyano Satoru
Project Team For Pharmacogenetics National Intitute Of Health Sciences
著作論文
- Dose-related changes of oxidative stress and cell proliferation in kidneys of male and female F344 rats exposed to potassium bromate
- A possible role of oxidative stress in potassium bromate (KBrO_3) carcinogenesis (ACTIVE OXYGEN) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Genetic Variations and Haplotype Structures of the ABC Transporter Gene ABCC1 in a Japanese Population
- Twenty-six Novel Single Nucleotide Polymorphisms and their Frequencies of the NR113 (CAR) Gene in a Japanese Population
- Eleven Novel Single Nucleotide Polymorphisms in the NR1I2 (PXR) Gene, Four of which Induce Non-synonymous Amino Acid Alterations
- Prevention by 2-Mercaptoethane Sulfonate and N-Acetylcysteine of Renal Oxidative Damage in Rats Treated with Ferric Nitrilotriacetate
- 日本人におけるABCC3遺伝子の多型解析
- REVISION AND ESTABLISHMENT OF JAPANESE DRINKING WATER QUALITY GUIDELINES FOR DI(2-ETHYLHEXYL) PHTHALATE, TOLUENE AND VINYL CHLORIDE : DIFFERENCES FROM THE LATEST WHO GUIDELINE DRAFTS
- COMPARATIVE STUDY OF TOXICITY OF 4-NITROPHENOL AND 2, 4-DINITROPHENOL IN NEWBORN AND YOUNG RATS
- A 13-WEEK TOXICITY STUDY OF SIMULTANEOUS ADMINISTRATION OF COCHINEAL AND ALUMINUM POTASSIUM SULFATE IN RATS
- P11-10 Kidney damages induced by tetrabromobisphenol A in newborn rats
- ACUTE, SUBCHRONIC AND CHRONIC TOXICITY STUDIES OF A SYNTHETIC ANTIOXIDANT, 2,2'-METHYLENEBIS(4-METHYL-6-TERT-BUTYLPHENOL) IN RATS
- CHRONIC ORAL TOXICITY STUDY OF A SYNTHETIC ANTIOXIDANT, 2, 2'-METHYLENEBIS(4-ETHYL-6-TERT-BUTYLPHENOL)(MBEBP)IN RATS
- TOXICITY STUDIES OF A SYNTHETIC ANTIOXIDANT, 2,2'-METHYLENEBIS (4-ETHYL-6-TERT-BUTYLPHENOL) IN RATS 1. ACUTE AND SUBCHRONIC TOXICITY
- "P-35 Contribution of Oxidative Stress to Rat Hepatotoxicity induced by 2-Nitropropane : Lipid Peroxidation and Inhibitory Effect of Green Tea.
- TOXICITY STUDIES OF A SYNTHETIC ANTIOXIDANT, 2,2'-METHYLENEBIS (4-ETHYL-6-TERT-BUTYLPHENOL) IN RATS 2. UNCOUPLING EFFECT ON OXIDATIVE PHOSPHORYLATION OF LIVER MITOCHONDRIA
- Repeated dose toxicity of 2-chlorophenol in newborn rats and comparison with that in young adult rats. (TEST METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Risk assessment for the endocrine distruption effects by bisphenol A (DEVELOPMENT AND REPRODUCTION) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Repeated dose toxicity of 3-ethylphenol in newborn rats and the comparison with that in young rats (GENERAL TOXICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- COMPARATIVE TOXICITY STUDY OF 3-AMINOPHENOL IN NEWBORN AND YOUNG RATS
- Repeated dose toxicity of 3-aminophenol in newborn rats and comparison with that in young rats.(GENERAL SESSION BY ORAL PRESENTATION)(GENERAL TOXICITY & NERVOUS SYSTEM)
- Repeated dose toxicity of 2,4,6-trinitrophenol in juvenile rats and the comparison with that in young adult rats.(GENERAL SESSION BY ORAL PRESENTATION)(GENERAL TOXICITY & NERVOUS SYSTEM)
- O12-10 The toxicity and NOELs of 4-chlorophenol in newborn and young rats
- Genetic Polymorphisms of Copper- and Platinum Drug-efflux Transporters ATP7A and ATP7B in Japanese Cancer Patients
- Ethnic Differences of two Non-synonymous Single Nucleotide Polymorphisms in CDA Gene
- Principles of risk assessment for determining the safety of chemicals : Recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate
- Prediction of Severe Adverse Drug Reactions Using Pharmacogenetic Biomarkers